SCHEMBL6422031

SCHEMBL6422031

CC(=O)OC[C@H]1O[C@@H](n2nc3ncnc(N)c3n2)[C@H](OC(C)=O)[C@@H]1OC(C)=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 2/20 0.52
▸ LMNA P02545 2/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ TP53 P04637 1/20 0.48
▸ MAPT P10636 1/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ THRB P10828 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ CA1 P00915 12/20 0.44
▸ CA2 P00918 12/20 0.44
▸ CA12 O43570 11/20 0.44
▸ CA9 Q16790 10/20 0.44
▸ CA14 Q9ULX7 8/20 0.44
▸ PRKAB2 O43741 1/20 0.44
▸ PRKAG1 P54619 1/20 0.44
▸ PRKAA2 P54646 1/20 0.44
▸ PRKAA1 Q13131 1/20 0.44
▸ PRKAG3 Q9UGI9 1/20 0.44
▸ PRKAG2 Q9UGJ0 1/20 0.44
▸ PRKAB1 Q9Y478 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4425824 0.80 ALDH1A1 (0.65) LMNAALDH1A1TP53MAPTTDP1
SCHEMBL13597931 0.80 ALDH1A1 (0.65) LMNAALDH1A1TP53MAPTTDP1
SCHEMBL31685764 0.80 ALDH1A1 (0.65) LMNAALDH1A1TP53MAPTTDP1
SCHEMBL8205660 0.80 ALDH1A1 (0.65) LMNAALDH1A1TP53MAPTTDP1
SCHEMBL19889158 0.80 ALDH1A1 (0.65) LMNAALDH1A1TP53MAPTTDP1
SCHEMBL23982402 0.80 ALDH1A1 (0.65) LMNAALDH1A1TP53MAPTTDP1
SCHEMBL10033986 0.80 ALDH1A1 (0.65) LMNAALDH1A1TP53MAPTTDP1
SCHEMBL11423681 0.80 ALDH1A1 (0.65) LMNAALDH1A1TP53MAPTTDP1
SCHEMBL6419293 0.79 LMNA (0.52) HIF1ALMNAALDH1A1TP53MAPT
SCHEMBL31685464 0.79 ALDH1A1 (0.54) HIF1ALMNAALDH1A1TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1589028-A2 Modified oligonucleotides, their preparation and their use Aventis Pharma Deutschland GmbH (DE) 2005-10-26 — — EP disclosed
EP-0680969-B1 Modified oligonucleotides, their preparation and their use AVENTIS PHARMA GMBH (DE) 2005-07-27 — — EP disclosed
US-6066720-A WITH AT LEAST ONE 8-AZAPURINE BASE; FORMS MORE STABLE HYBRIDIZATION COMPLEXES WITH NUCLEIC ACIDS; FOR ANTISENSE AGENTS, DIAGNOSTIC AGENTS, PROBES, PRIMERS HOECHST AKTIENGESELLSCHAFT (DE) 2000-05-23 — — US disclosed
EP-0680969-A2 Modified oligonucleotides, their preparation and their use HOECHST AKTIENGESELLSCHAFT (DE) 1995-11-08 — — EP disclosed
Send feedback